Osteopontin Upregulation, Induced by the Continuous Mechanical Load in Adipose Tissue-Derived Mesenchymal Stem Cells, is Strongly Restricted in INF-γ/TNF-α/IL-22 Microenvironment

Inflammation. 2023 Dec;46(6):2270-2275. doi: 10.1007/s10753-023-01876-5. Epub 2023 Jul 24.

Abstract

The osteogenic potential of mesenchymal stem cells (MSc) in axial spondyloarthritis (AxSpA) depends on the interplay of inflammation and multiple hormonal and local mechanical factors. In this study, MCs, derived from the adipose tissue of a healthy donor, were cultured under or without continuous mechanical load in the osteogenic differentiation medium with or without the addition of testosterone, cocktail of INF-γ/TNF-α/IL-22, or both. Real-time PCR for osteogenic transcription factors demonstrated that in the absence of INF-γ/TNF-α/IL-22, mechanical load causes significant upregulation of SPP1 (osteopontin), while the presence of the inflammatory cytokines almost completely abolishes this effect. In addition, exposure to INF-γ/TNF-α/IL-22 slightly upregulated BMP2, but suppressed the expression of ALPL, Col1A1, and SPP1, reinforcing the hypothesis that the inflammatory environment allows MSc to commit toward the IL-22-driven osteogenic differentiation but can restrict the later stages of osteogenesis. In summary, osteopontin can play a role in the pathogenesis of AxSpA, linking between mechanical load and pathological bone formation.

Keywords: Ankylosing spondylitis; Axial spondyloarthritis; Inflammation; Mechanical load; Mesenchymal stem cell; Osteogenesis; Osteopontin; Testosterone.

MeSH terms

  • Axial Spondyloarthritis*
  • Cell Differentiation
  • Cells, Cultured
  • Humans
  • Interleukin-22
  • Mesenchymal Stem Cells* / metabolism
  • Osteogenesis
  • Osteopontin / genetics
  • Osteopontin / metabolism
  • Osteopontin / pharmacology
  • Tumor Necrosis Factor-alpha / metabolism
  • Up-Regulation

Substances

  • Tumor Necrosis Factor-alpha
  • Osteopontin